nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminolevulinic acid—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.107	0.136	CbGbCtD
Aminolevulinic acid—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.095	0.121	CbGbCtD
Aminolevulinic acid—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0918	0.117	CbGbCtD
Aminolevulinic acid—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0846	0.108	CbGbCtD
Aminolevulinic acid—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0818	0.104	CbGbCtD
Aminolevulinic acid—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0807	0.103	CbGbCtD
Aminolevulinic acid—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0729	0.0929	CbGbCtD
Aminolevulinic acid—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0696	0.0886	CbGbCtD
Aminolevulinic acid—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0545	0.0695	CbGbCtD
Aminolevulinic acid—SLC15A1—Glyburide—type 2 diabetes mellitus	0.047	0.0599	CbGbCtD
Aminolevulinic acid—ALAD—islet of Langerhans—type 2 diabetes mellitus	0.00489	0.135	CbGeAlD
Aminolevulinic acid—ALAD—nephron tubule—type 2 diabetes mellitus	0.00394	0.109	CbGeAlD
Aminolevulinic acid—ALAD—Porphyrin metabolism—HMOX1—type 2 diabetes mellitus	0.00386	0.125	CbGpPWpGaD
Aminolevulinic acid—ALAD—cardiovascular system—type 2 diabetes mellitus	0.00354	0.0976	CbGeAlD
Aminolevulinic acid—ALAD—kidney—type 2 diabetes mellitus	0.00346	0.0955	CbGeAlD
Aminolevulinic acid—ALAD—pancreas—type 2 diabetes mellitus	0.00344	0.0948	CbGeAlD
Aminolevulinic acid—ALAD—cortex of kidney—type 2 diabetes mellitus	0.00337	0.093	CbGeAlD
Aminolevulinic acid—ALAD—adipose tissue—type 2 diabetes mellitus	0.00312	0.086	CbGeAlD
Aminolevulinic acid—Aminocaproic Acid—PLAT—type 2 diabetes mellitus	0.00254	0.5	CrCbGaD
Aminolevulinic acid—Succinic acid—OXCT1—type 2 diabetes mellitus	0.00254	0.5	CrCbGaD
Aminolevulinic acid—ALAD—liver—type 2 diabetes mellitus	0.00219	0.0603	CbGeAlD
Aminolevulinic acid—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.00173	0.0477	CbGeAlD
Aminolevulinic acid—SLC15A1—kidney—type 2 diabetes mellitus	0.00152	0.0419	CbGeAlD
Aminolevulinic acid—SLC15A2—retina—type 2 diabetes mellitus	0.00115	0.0317	CbGeAlD
Aminolevulinic acid—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.00108	0.0298	CbGeAlD
Aminolevulinic acid—SLC15A1—liver—type 2 diabetes mellitus	0.00096	0.0265	CbGeAlD
Aminolevulinic acid—SLC15A2—kidney—type 2 diabetes mellitus	0.00095	0.0262	CbGeAlD
Aminolevulinic acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000936	0.0303	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000925	0.0255	CbGeAlD
Aminolevulinic acid—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000869	0.0281	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—BHMT—type 2 diabetes mellitus	0.000431	0.0139	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000419	0.0135	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000388	0.0126	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—AANAT—type 2 diabetes mellitus	0.000377	0.0122	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PTGDS—type 2 diabetes mellitus	0.000377	0.0122	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CDO1—type 2 diabetes mellitus	0.000357	0.0115	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GPD2—type 2 diabetes mellitus	0.000357	0.0115	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—AK1—type 2 diabetes mellitus	0.000341	0.011	CbGpPWpGaD
Aminolevulinic acid—Chills—Gliclazide—type 2 diabetes mellitus	0.000322	0.00225	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000321	0.00224	CcSEcCtD
Aminolevulinic acid—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000321	0.00224	CcSEcCtD
Aminolevulinic acid—Anaemia—Glyburide—type 2 diabetes mellitus	0.000321	0.00224	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000318	0.00222	CcSEcCtD
Aminolevulinic acid—Nausea—Acarbose—type 2 diabetes mellitus	0.000317	0.00221	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.000316	0.00221	CcSEcCtD
Aminolevulinic acid—Pain—Glipizide—type 2 diabetes mellitus	0.000315	0.0022	CcSEcCtD
Aminolevulinic acid—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000315	0.0022	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000315	0.0102	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—MAT1A—type 2 diabetes mellitus	0.000315	0.0102	CbGpPWpGaD
Aminolevulinic acid—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000314	0.00219	CcSEcCtD
Aminolevulinic acid—Erythema—Gliclazide—type 2 diabetes mellitus	0.000312	0.00218	CcSEcCtD
Aminolevulinic acid—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00031	0.00217	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000309	0.00216	CcSEcCtD
Aminolevulinic acid—Infection—Bromocriptine—type 2 diabetes mellitus	0.000308	0.00215	CcSEcCtD
Aminolevulinic acid—Tension—Gliclazide—type 2 diabetes mellitus	0.000306	0.00214	CcSEcCtD
Aminolevulinic acid—Nausea—Nateglinide—type 2 diabetes mellitus	0.000306	0.00213	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000306	0.00213	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000305	0.00213	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000305	0.00213	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000304	0.00212	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—G6PC—type 2 diabetes mellitus	0.000304	0.00982	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000304	0.00982	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HBA2—type 2 diabetes mellitus	0.000304	0.00982	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ND1—type 2 diabetes mellitus	0.000304	0.00982	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ENPP1—type 2 diabetes mellitus	0.000304	0.00982	CbGpPWpGaD
Aminolevulinic acid—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000304	0.00212	CcSEcCtD
Aminolevulinic acid—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000303	0.00212	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000302	0.00974	CbGpPWpGaD
Aminolevulinic acid—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000301	0.0021	CcSEcCtD
Aminolevulinic acid—Convulsion—Glyburide—type 2 diabetes mellitus	0.000301	0.0021	CcSEcCtD
Aminolevulinic acid—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000299	0.00209	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000298	0.00208	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000298	0.00208	CcSEcCtD
Aminolevulinic acid—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000298	0.00208	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000297	0.00207	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000296	0.00207	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GCGR—type 2 diabetes mellitus	0.000294	0.00951	CbGpPWpGaD
Aminolevulinic acid—Pain—Sitagliptin—type 2 diabetes mellitus	0.000293	0.00205	CcSEcCtD
Aminolevulinic acid—Urticaria—Glipizide—type 2 diabetes mellitus	0.000293	0.00204	CcSEcCtD
Aminolevulinic acid—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00029	0.00202	CcSEcCtD
Aminolevulinic acid—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000288	0.00201	CcSEcCtD
Aminolevulinic acid—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000288	0.00201	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000288	0.00201	CcSEcCtD
Aminolevulinic acid—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000285	0.00199	CcSEcCtD
Aminolevulinic acid—Oedema—Glyburide—type 2 diabetes mellitus	0.000284	0.00198	CcSEcCtD
Aminolevulinic acid—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000283	0.00198	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000281	0.00197	CcSEcCtD
Aminolevulinic acid—Rash—Repaglinide—type 2 diabetes mellitus	0.000281	0.00196	CcSEcCtD
Aminolevulinic acid—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00028	0.00196	CcSEcCtD
Aminolevulinic acid—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00028	0.00196	CcSEcCtD
Aminolevulinic acid—Eye disorder—Metformin—type 2 diabetes mellitus	0.00028	0.00196	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.00028	0.00904	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000279	0.00902	CbGpPWpGaD
Aminolevulinic acid—Headache—Repaglinide—type 2 diabetes mellitus	0.000279	0.00195	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000278	0.00195	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000278	0.00194	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000278	0.00194	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYTB—type 2 diabetes mellitus	0.000278	0.00898	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—OXCT1—type 2 diabetes mellitus	0.000278	0.00898	CbGpPWpGaD
Aminolevulinic acid—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000278	0.00194	CcSEcCtD
Aminolevulinic acid—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000273	0.00191	CcSEcCtD
Aminolevulinic acid—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000272	0.0019	CcSEcCtD
Aminolevulinic acid—Angiopathy—Metformin—type 2 diabetes mellitus	0.000272	0.0019	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000271	0.00875	CbGpPWpGaD
Aminolevulinic acid—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00027	0.00189	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.00027	0.00871	CbGpPWpGaD
Aminolevulinic acid—Chills—Metformin—type 2 diabetes mellitus	0.000269	0.00188	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000268	0.00187	CcSEcCtD
Aminolevulinic acid—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000265	0.00185	CcSEcCtD
Aminolevulinic acid—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000265	0.00185	CcSEcCtD
Aminolevulinic acid—Hypotension—Glyburide—type 2 diabetes mellitus	0.000265	0.00185	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000265	0.00185	CcSEcCtD
Aminolevulinic acid—Nausea—Repaglinide—type 2 diabetes mellitus	0.000264	0.00185	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000264	0.00184	CcSEcCtD
Aminolevulinic acid—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000264	0.00184	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000263	0.00183	CcSEcCtD
Aminolevulinic acid—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000262	0.00183	CcSEcCtD
Aminolevulinic acid—Erythema—Metformin—type 2 diabetes mellitus	0.000261	0.00182	CcSEcCtD
Aminolevulinic acid—Pruritus—Glipizide—type 2 diabetes mellitus	0.000261	0.00182	CcSEcCtD
Aminolevulinic acid—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.00026	0.00182	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000259	0.00837	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ACACA—type 2 diabetes mellitus	0.000258	0.00835	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000258	0.00835	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—STAR—type 2 diabetes mellitus	0.000258	0.00835	CbGpPWpGaD
Aminolevulinic acid—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000257	0.00179	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000255	0.00178	CcSEcCtD
Aminolevulinic acid—Chills—Irbesartan—type 2 diabetes mellitus	0.000254	0.00177	CcSEcCtD
Aminolevulinic acid—Infection—Gliclazide—type 2 diabetes mellitus	0.000253	0.00177	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000252	0.00176	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.00025	0.00809	CbGpPWpGaD
Aminolevulinic acid—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00025	0.00175	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00025	0.00174	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000249	0.00174	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CBS—type 2 diabetes mellitus	0.000248	0.008	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ABCC8—type 2 diabetes mellitus	0.000248	0.008	CbGpPWpGaD
Aminolevulinic acid—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000247	0.00173	CcSEcCtD
Aminolevulinic acid—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000246	0.00172	CcSEcCtD
Aminolevulinic acid—Erythema—Irbesartan—type 2 diabetes mellitus	0.000246	0.00172	CcSEcCtD
Aminolevulinic acid—Convulsion—Orlistat—type 2 diabetes mellitus	0.000245	0.00171	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000245	0.00171	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000245	0.00171	CcSEcCtD
Aminolevulinic acid—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000243	0.0017	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000242	0.00169	CcSEcCtD
Aminolevulinic acid—Tension—Irbesartan—type 2 diabetes mellitus	0.000242	0.00169	CcSEcCtD
Aminolevulinic acid—Angiopathy—Losartan—type 2 diabetes mellitus	0.000242	0.00169	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000241	0.00169	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000241	0.00168	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000239	0.00167	CcSEcCtD
Aminolevulinic acid—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000239	0.00167	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—COX2—type 2 diabetes mellitus	0.000238	0.0077	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000238	0.0077	CbGpPWpGaD
Aminolevulinic acid—Discomfort—Orlistat—type 2 diabetes mellitus	0.000238	0.00166	CcSEcCtD
Aminolevulinic acid—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000238	0.00166	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000235	0.00164	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000234	0.00164	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NCOA6—type 2 diabetes mellitus	0.000234	0.00757	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Glipizide—type 2 diabetes mellitus	0.000234	0.00164	CcSEcCtD
Aminolevulinic acid—Oedema—Valsartan—type 2 diabetes mellitus	0.000234	0.00163	CcSEcCtD
Aminolevulinic acid—Infection—Valsartan—type 2 diabetes mellitus	0.000232	0.00162	CcSEcCtD
Aminolevulinic acid—Rash—Glipizide—type 2 diabetes mellitus	0.000232	0.00162	CcSEcCtD
Aminolevulinic acid—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000232	0.00162	CcSEcCtD
Aminolevulinic acid—Erythema—Losartan—type 2 diabetes mellitus	0.000232	0.00162	CcSEcCtD
Aminolevulinic acid—Oedema—Orlistat—type 2 diabetes mellitus	0.000231	0.00161	CcSEcCtD
Aminolevulinic acid—Headache—Glipizide—type 2 diabetes mellitus	0.000231	0.00161	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—UCP3—type 2 diabetes mellitus	0.00023	0.00744	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—UCP2—type 2 diabetes mellitus	0.00023	0.00744	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HSD11B1—type 2 diabetes mellitus	0.00023	0.00744	CbGpPWpGaD
Aminolevulinic acid—Infection—Orlistat—type 2 diabetes mellitus	0.00023	0.0016	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000229	0.0016	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000229	0.0016	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000229	0.0016	CcSEcCtD
Aminolevulinic acid—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000228	0.00159	CcSEcCtD
Aminolevulinic acid—Tension—Losartan—type 2 diabetes mellitus	0.000227	0.00159	CcSEcCtD
Aminolevulinic acid—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000227	0.00159	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000227	0.00158	CcSEcCtD
Aminolevulinic acid—Urticaria—Glyburide—type 2 diabetes mellitus	0.000225	0.00157	CcSEcCtD
Aminolevulinic acid—Nervousness—Losartan—type 2 diabetes mellitus	0.000225	0.00157	CcSEcCtD
Aminolevulinic acid—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000224	0.00157	CcSEcCtD
Aminolevulinic acid—Headache—Pioglitazone—type 2 diabetes mellitus	0.000221	0.00154	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000221	0.00154	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.00022	0.0071	CbGpPWpGaD
Aminolevulinic acid—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00022	0.00154	CcSEcCtD
Aminolevulinic acid—Discomfort—Metformin—type 2 diabetes mellitus	0.00022	0.00153	CcSEcCtD
Aminolevulinic acid—Nausea—Glipizide—type 2 diabetes mellitus	0.000219	0.00153	CcSEcCtD
Aminolevulinic acid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000219	0.00153	CcSEcCtD
Aminolevulinic acid—Hypotension—Valsartan—type 2 diabetes mellitus	0.000219	0.00153	CcSEcCtD
Aminolevulinic acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000218	0.00152	CcSEcCtD
Aminolevulinic acid—Pain—Gliclazide—type 2 diabetes mellitus	0.000218	0.00152	CcSEcCtD
Aminolevulinic acid—Rash—Glimepiride—type 2 diabetes mellitus	0.000217	0.00151	CcSEcCtD
Aminolevulinic acid—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000217	0.00151	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—PCK1—type 2 diabetes mellitus	0.000216	0.007	CbGpPWpGaD
Aminolevulinic acid—Rash—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00151	CcSEcCtD
Aminolevulinic acid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00151	CcSEcCtD
Aminolevulinic acid—Headache—Glimepiride—type 2 diabetes mellitus	0.000215	0.0015	CcSEcCtD
Aminolevulinic acid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000215	0.0015	CcSEcCtD
Aminolevulinic acid—Anaemia—Losartan—type 2 diabetes mellitus	0.000214	0.0015	CcSEcCtD
Aminolevulinic acid—Oedema—Metformin—type 2 diabetes mellitus	0.000213	0.00149	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000213	0.00687	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000212	0.00148	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000212	0.00684	CbGpPWpGaD
Aminolevulinic acid—Infection—Metformin—type 2 diabetes mellitus	0.000212	0.00148	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00021	0.00147	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000209	0.00146	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000209	0.00146	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000208	0.00145	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000208	0.00145	CcSEcCtD
Aminolevulinic acid—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000207	0.00145	CcSEcCtD
Aminolevulinic acid—Skin disorder—Metformin—type 2 diabetes mellitus	0.000207	0.00145	CcSEcCtD
Aminolevulinic acid—Nausea—Glimepiride—type 2 diabetes mellitus	0.000204	0.00143	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000204	0.00659	CbGpPWpGaD
Aminolevulinic acid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00142	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—HK1—type 2 diabetes mellitus	0.000203	0.00655	CbGpPWpGaD
Aminolevulinic acid—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000202	0.00141	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000202	0.00141	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000201	0.00141	CcSEcCtD
Aminolevulinic acid—Oedema—Irbesartan—type 2 diabetes mellitus	0.000201	0.0014	CcSEcCtD
Aminolevulinic acid—Pruritus—Glyburide—type 2 diabetes mellitus	0.000201	0.0014	CcSEcCtD
Aminolevulinic acid—Mental disorder—Ramipril—type 2 diabetes mellitus	0.0002	0.0014	CcSEcCtD
Aminolevulinic acid—Infection—Irbesartan—type 2 diabetes mellitus	0.0002	0.00139	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.0002	0.00139	CcSEcCtD
Aminolevulinic acid—Hypotension—Metformin—type 2 diabetes mellitus	0.000199	0.00139	CcSEcCtD
Aminolevulinic acid—Erythema—Ramipril—type 2 diabetes mellitus	0.000199	0.00139	CcSEcCtD
Aminolevulinic acid—Pain—Orlistat—type 2 diabetes mellitus	0.000198	0.00138	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000197	0.00638	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000197	0.00138	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000197	0.00138	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000197	0.00137	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000196	0.00635	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—LPA—type 2 diabetes mellitus	0.000196	0.00633	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GCKR—type 2 diabetes mellitus	0.000196	0.00633	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000196	0.00633	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000196	0.00633	CbGpPWpGaD
Aminolevulinic acid—Rash—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00137	CcSEcCtD
Aminolevulinic acid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000195	0.00136	CcSEcCtD
Aminolevulinic acid—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000195	0.00136	CcSEcCtD
Aminolevulinic acid—Tension—Ramipril—type 2 diabetes mellitus	0.000195	0.00136	CcSEcCtD
Aminolevulinic acid—Discomfort—Losartan—type 2 diabetes mellitus	0.000195	0.00136	CcSEcCtD
Aminolevulinic acid—Headache—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00136	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000194	0.00136	CcSEcCtD
Aminolevulinic acid—Nervousness—Ramipril—type 2 diabetes mellitus	0.000193	0.00135	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000191	0.00134	CcSEcCtD
Aminolevulinic acid—Oedema—Losartan—type 2 diabetes mellitus	0.000189	0.00132	CcSEcCtD
Aminolevulinic acid—Infection—Losartan—type 2 diabetes mellitus	0.000188	0.00131	CcSEcCtD
Aminolevulinic acid—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000188	0.00131	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ALDOB—type 2 diabetes mellitus	0.000188	0.00607	CbGpPWpGaD
Aminolevulinic acid—Urticaria—Valsartan—type 2 diabetes mellitus	0.000186	0.0013	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000186	0.0013	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000185	0.00129	CcSEcCtD
Aminolevulinic acid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00129	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000184	0.00128	CcSEcCtD
Aminolevulinic acid—Urticaria—Orlistat—type 2 diabetes mellitus	0.000184	0.00128	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000183	0.00128	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00018	0.00126	CcSEcCtD
Aminolevulinic acid—Vomiting—Glyburide—type 2 diabetes mellitus	0.00018	0.00126	CcSEcCtD
Aminolevulinic acid—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00018	0.00126	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.00018	0.00581	CbGpPWpGaD
Aminolevulinic acid—Rash—Glyburide—type 2 diabetes mellitus	0.000179	0.00125	CcSEcCtD
Aminolevulinic acid—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000179	0.00125	CcSEcCtD
Aminolevulinic acid—Headache—Glyburide—type 2 diabetes mellitus	0.000178	0.00124	CcSEcCtD
Aminolevulinic acid—Hypotension—Losartan—type 2 diabetes mellitus	0.000177	0.00123	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GLP1R—type 2 diabetes mellitus	0.000175	0.00564	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000174	0.00122	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000174	0.00562	CbGpPWpGaD
Aminolevulinic acid—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000174	0.00121	CcSEcCtD
Aminolevulinic acid—Convulsion—Ramipril—type 2 diabetes mellitus	0.000172	0.0012	CcSEcCtD
Aminolevulinic acid—Pain—Irbesartan—type 2 diabetes mellitus	0.000172	0.0012	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00017	0.00119	CcSEcCtD
Aminolevulinic acid—Urticaria—Metformin—type 2 diabetes mellitus	0.000169	0.00118	CcSEcCtD
Aminolevulinic acid—Nausea—Glyburide—type 2 diabetes mellitus	0.000168	0.00118	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000168	0.00117	CcSEcCtD
Aminolevulinic acid—Discomfort—Ramipril—type 2 diabetes mellitus	0.000167	0.00117	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000167	0.0054	CbGpPWpGaD
Aminolevulinic acid—Pruritus—Valsartan—type 2 diabetes mellitus	0.000165	0.00116	CcSEcCtD
Aminolevulinic acid—Pruritus—Orlistat—type 2 diabetes mellitus	0.000164	0.00114	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000163	0.00526	CbGpPWpGaD
Aminolevulinic acid—Oedema—Ramipril—type 2 diabetes mellitus	0.000162	0.00113	CcSEcCtD
Aminolevulinic acid—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000162	0.00113	CcSEcCtD
Aminolevulinic acid—Pain—Losartan—type 2 diabetes mellitus	0.000162	0.00113	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000161	0.00521	CbGpPWpGaD
Aminolevulinic acid—Rash—Gliclazide—type 2 diabetes mellitus	0.000161	0.00112	CcSEcCtD
Aminolevulinic acid—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00016	0.00112	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00016	0.00112	CcSEcCtD
Aminolevulinic acid—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00016	0.00112	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CPT1A—type 2 diabetes mellitus	0.00016	0.00516	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—MTR—type 2 diabetes mellitus	0.00016	0.00516	CbGpPWpGaD
Aminolevulinic acid—Headache—Gliclazide—type 2 diabetes mellitus	0.000159	0.00111	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000159	0.00111	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000159	0.00111	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000159	0.00111	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000158	0.0011	CcSEcCtD
Aminolevulinic acid—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000158	0.0011	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NAMPT—type 2 diabetes mellitus	0.000157	0.00506	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—LIPC—type 2 diabetes mellitus	0.000156	0.00503	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HBA1—type 2 diabetes mellitus	0.000156	0.00503	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GCK—type 2 diabetes mellitus	0.000156	0.00503	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000155	0.00499	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000152	0.00491	CbGpPWpGaD
Aminolevulinic acid—Hypotension—Ramipril—type 2 diabetes mellitus	0.000152	0.00106	CcSEcCtD
Aminolevulinic acid—Nausea—Gliclazide—type 2 diabetes mellitus	0.000151	0.00106	CcSEcCtD
Aminolevulinic acid—Pruritus—Metformin—type 2 diabetes mellitus	0.000151	0.00105	CcSEcCtD
Aminolevulinic acid—Urticaria—Losartan—type 2 diabetes mellitus	0.00015	0.00105	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CETP—type 2 diabetes mellitus	0.00015	0.00485	CbGpPWpGaD
Aminolevulinic acid—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00015	0.00104	CcSEcCtD
Aminolevulinic acid—Vomiting—Valsartan—type 2 diabetes mellitus	0.000149	0.00104	CcSEcCtD
Aminolevulinic acid—Rash—Valsartan—type 2 diabetes mellitus	0.000147	0.00103	CcSEcCtD
Aminolevulinic acid—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000147	0.00103	CcSEcCtD
Aminolevulinic acid—Vomiting—Orlistat—type 2 diabetes mellitus	0.000147	0.00103	CcSEcCtD
Aminolevulinic acid—Headache—Valsartan—type 2 diabetes mellitus	0.000147	0.00102	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000146	0.00102	CcSEcCtD
Aminolevulinic acid—Rash—Orlistat—type 2 diabetes mellitus	0.000146	0.00102	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000146	0.00102	CcSEcCtD
Aminolevulinic acid—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000146	0.00102	CcSEcCtD
Aminolevulinic acid—Headache—Orlistat—type 2 diabetes mellitus	0.000145	0.00101	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000145	0.00467	CbGpPWpGaD
Aminolevulinic acid—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000142	0.000993	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000142	0.00459	CbGpPWpGaD
Aminolevulinic acid—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00014	0.000978	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—PSMD6—type 2 diabetes mellitus	0.00014	0.00451	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SNAP25—type 2 diabetes mellitus	0.00014	0.00451	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SREBF1—type 2 diabetes mellitus	0.00014	0.00451	CbGpPWpGaD
Aminolevulinic acid—Nausea—Valsartan—type 2 diabetes mellitus	0.000139	0.000971	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000138	0.00446	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000138	0.000961	CcSEcCtD
Aminolevulinic acid—Nausea—Orlistat—type 2 diabetes mellitus	0.000137	0.000959	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000137	0.00443	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000137	0.00443	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CTGF—type 2 diabetes mellitus	0.000137	0.00442	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HMGCR—type 2 diabetes mellitus	0.000136	0.00439	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Metformin—type 2 diabetes mellitus	0.000135	0.000946	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000135	0.00435	CbGpPWpGaD
Aminolevulinic acid—Rash—Metformin—type 2 diabetes mellitus	0.000134	0.000938	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000134	0.00434	CbGpPWpGaD
Aminolevulinic acid—Dermatitis—Metformin—type 2 diabetes mellitus	0.000134	0.000937	CcSEcCtD
Aminolevulinic acid—Pruritus—Losartan—type 2 diabetes mellitus	0.000134	0.000935	CcSEcCtD
Aminolevulinic acid—Headache—Metformin—type 2 diabetes mellitus	0.000133	0.000932	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000133	0.00429	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000132	0.00426	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000129	0.000904	CcSEcCtD
Aminolevulinic acid—Urticaria—Ramipril—type 2 diabetes mellitus	0.000129	0.0009	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000128	0.000896	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000128	0.00414	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000128	0.000893	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000128	0.00412	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000127	0.00411	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000127	0.00411	CbGpPWpGaD
Aminolevulinic acid—Rash—Irbesartan—type 2 diabetes mellitus	0.000127	0.000885	CcSEcCtD
Aminolevulinic acid—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000127	0.000885	CcSEcCtD
Aminolevulinic acid—Nausea—Metformin—type 2 diabetes mellitus	0.000127	0.000884	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000126	0.00408	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000126	0.00408	CbGpPWpGaD
Aminolevulinic acid—Headache—Irbesartan—type 2 diabetes mellitus	0.000126	0.00088	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000125	0.00405	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000125	0.00404	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000123	0.00398	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000121	0.00391	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GCG—type 2 diabetes mellitus	0.000121	0.00391	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Losartan—type 2 diabetes mellitus	0.00012	0.00084	CcSEcCtD
Aminolevulinic acid—Nausea—Irbesartan—type 2 diabetes mellitus	0.000119	0.000834	CcSEcCtD
Aminolevulinic acid—Rash—Losartan—type 2 diabetes mellitus	0.000119	0.000833	CcSEcCtD
Aminolevulinic acid—Dermatitis—Losartan—type 2 diabetes mellitus	0.000119	0.000832	CcSEcCtD
Aminolevulinic acid—Headache—Losartan—type 2 diabetes mellitus	0.000118	0.000828	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000116	0.00376	CbGpPWpGaD
Aminolevulinic acid—Pruritus—Ramipril—type 2 diabetes mellitus	0.000115	0.000802	CcSEcCtD
Aminolevulinic acid—Nausea—Losartan—type 2 diabetes mellitus	0.000112	0.000785	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000112	0.00362	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000112	0.00361	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000112	0.00361	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000111	0.000775	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000108	0.00347	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000108	0.00347	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000107	0.00347	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000106	0.00341	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GNB3—type 2 diabetes mellitus	0.000104	0.00337	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000104	0.00337	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000104	0.00336	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HMOX1—type 2 diabetes mellitus	0.000104	0.00335	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000104	0.00335	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000104	0.00335	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Ramipril—type 2 diabetes mellitus	0.000103	0.00072	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CAT—type 2 diabetes mellitus	0.000102	0.00331	CbGpPWpGaD
Aminolevulinic acid—Rash—Ramipril—type 2 diabetes mellitus	0.000102	0.000714	CcSEcCtD
Aminolevulinic acid—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000102	0.000714	CcSEcCtD
Aminolevulinic acid—Headache—Ramipril—type 2 diabetes mellitus	0.000102	0.00071	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	9.98e-05	0.00322	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	9.98e-05	0.00322	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	9.96e-05	0.00322	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—APOB—type 2 diabetes mellitus	9.94e-05	0.00321	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	9.8e-05	0.00317	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	9.76e-05	0.00316	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GSTM1—type 2 diabetes mellitus	9.67e-05	0.00312	CbGpPWpGaD
Aminolevulinic acid—Nausea—Ramipril—type 2 diabetes mellitus	9.63e-05	0.000673	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—LPL—type 2 diabetes mellitus	9.49e-05	0.00307	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ADCY5—type 2 diabetes mellitus	9.29e-05	0.003	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GPX1—type 2 diabetes mellitus	9.26e-05	0.00299	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	9.14e-05	0.00295	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	9.13e-05	0.00295	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	9.06e-05	0.00293	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CD36—type 2 diabetes mellitus	9.02e-05	0.00291	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PPP2CA—type 2 diabetes mellitus	8.91e-05	0.00288	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	8.83e-05	0.00285	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—MTHFR—type 2 diabetes mellitus	8.55e-05	0.00276	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	8.49e-05	0.00274	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	8.47e-05	0.00274	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	8.47e-05	0.00274	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PPARA—type 2 diabetes mellitus	8.38e-05	0.00271	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	8.2e-05	0.00265	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—AGT—type 2 diabetes mellitus	8.12e-05	0.00262	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CALM1—type 2 diabetes mellitus	7.98e-05	0.00258	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—APOE—type 2 diabetes mellitus	7.96e-05	0.00257	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—APOA1—type 2 diabetes mellitus	7.86e-05	0.00254	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.86e-05	0.00254	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	7.35e-05	0.00237	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	7.02e-05	0.00227	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	7.02e-05	0.00227	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PPARG—type 2 diabetes mellitus	6.93e-05	0.00224	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.85e-05	0.00221	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.82e-05	0.0022	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.81e-05	0.0022	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—INS—type 2 diabetes mellitus	6.8e-05	0.0022	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.77e-05	0.00219	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.51e-05	0.0021	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.51e-05	0.0021	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.36e-05	0.00205	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.32e-05	0.00204	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.28e-05	0.00203	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ALB—type 2 diabetes mellitus	6.23e-05	0.00201	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.97e-05	0.00193	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—NOS3—type 2 diabetes mellitus	5.96e-05	0.00193	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PIK3R1—type 2 diabetes mellitus	5.96e-05	0.00193	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.69e-05	0.00184	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.54e-05	0.00179	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.53e-05	0.00179	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.46e-05	0.00176	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PTGS2—type 2 diabetes mellitus	5.45e-05	0.00176	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.28e-05	0.00171	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.13e-05	0.00166	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.06e-05	0.00164	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.7e-05	0.00152	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.68e-05	0.00151	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.64e-05	0.0015	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.48e-05	0.00145	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.36e-05	0.00141	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.34e-05	0.0014	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.31e-05	0.00139	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.19e-05	0.00135	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.16e-05	0.00134	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.89e-05	0.00126	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.78e-05	0.00122	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.55e-05	0.00115	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.51e-05	0.00113	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.29e-05	0.00106	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.81e-05	0.000908	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—AKT1—type 2 diabetes mellitus	2.74e-05	0.000885	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.61e-05	0.000843	CbGpPWpGaD
